In several populations, small proportions of individuals remain human immunodeficiency virus (HIV)-seronegative, despite frequent sexual exposure to HIV,
which suggests that host factors may contribute to protection against infection [1] [2] [3] [4] [5] . Proposed correlates of protection against HIV infection in HIV-exposed seronegative (ESN) subjects that are well documented include inherited and acquired host factors, such as a homozygous 32-bp deletion in the gene encoding the HIV-1 coreceptor CCR5 [6] [7] [8] [9] [10] [11] , particular genetic HLA polymorphisms [12, 13] , mucosal and systemic anti-HIV IgA [14] [15] [16] [17] [18] , and HIV-specific helper and cytotoxic T cells [19] [20] [21] [22] [23] [24] [25] .
In addition to CD4, the b-chemokine receptor CCR5 is used as a coreceptor by primary macrophage (M)-tropic HIV-1 strains that are sexually transmitted [26] [27] [28] [29] , whereas the a-chemokine receptor CXCR4 is used by T cell (T)-tropic variants of HIV-1 that emerge at later disease stages [30] [31] [32] . Decreased expression levels of CCR5 on CD4 ϩ T cells, in the absence of the 32-bp deletion, have been correlated to decreased suscepti-bility to M-tropic HIV-1 in vitro [33, 34] , to decreased HIV-1 load levels in infected subjects [35] , and to increased protection against HIV-1 infection in ESN subjects [36] . However, studies exist in which the latter could not be confirmed [37, 38] . Although susceptibility to T-tropic HIV-1 strains in vitro has been correlated directly to CXCR4 expression levels [39] [40] [41] , no associations have been found between CXCR4 levels and the transmission of HIV-1 in vivo. b-chemokines are the natural ligands for the CCR5 coreceptor, and, although their HIV-suppressive capacity has been shown in vitro [42] , their role in protection against HIV infection in vivo remains controversial. Some studies have found increased b-chemokine levels in ESN subjects, compared with those in unexposed control subjects [25, 36, [43] [44] [45] . However, other studies have not found any difference [37, 38, 46] . Similarly, Th1 cytokines could play a role in protection against infection with HIV in association with cell-mediated immunity [47] . Indeed, among ESN populations, increased levels of Th1 cytokines have been shown in the presence of mucosal and systemic cellular immune activation [48] or together with a decreased Th2 cytokine profile [49, 50] . However, in other studies, decreased Th1 cytokine production was found among ESN subjects [46, 51] .
In the present study, we determined whether African ESN female sex workers (FSWs) differed from African HIV-seronegative female blood donors in one or several immunological aspects with potential HIV-protective capacity. Freshly obtained whole-blood samples were used to measure ex vivo cell surface expression levels of immune activation markers and HIV-1 coreceptors and to detect intracellular b-chemokine and cytokine production, all at the level of a single cell, by flow cytometry. In addition, we verified whether these potential correlates of HIV protection were associated with indicative markers of HIV exposure among FSWs, such as the duration of commercial sex work, the number of clients per day, the consistency in using condoms, and the occurrence of sexually transmitted infections (STIs).
SUBJECTS AND METHODS

Study population.
HIV-seronegative FSWs were enrolled consecutively as part of an ongoing surveillance study at a confidential clinic in Abidjan [52] , and blood samples and standard questionnaires with information on sociodemographics and sexual behavior were collected. Voluntary HIV-seronegative female blood donors were enrolled at the national blood transfusion center in Abidjan; only blood samples were collected. The study lasted 2 months and took place in 2 distinct 1-month time periods. In November 1999, 14 FSWs and 15 blood donors were enrolled; in May 2000, 13 FSWs and 12 blood donors were enrolled.
Laboratory methods for HIV and STI diagnosis. Whole blood was drawn from FSWs and control subjects into EDTA tubes (Becton Dickinson). Within 4 h of blood collection, plasma was separated from cells by centrifugation at 500 g, aliquoted, and stored at Ϫ70ЊC. The HIV-seronegative status of all subjects was determined in plasma by use of the current HIV testing algorithm of Projet RETRO-Cô te d'Ivoire, defined by a combination of ELISAs and Western blots [53, 54] . The HIV-negative status of ESN FSWs was confirmed by reverse HIV-1 reverse-transcriptase (RT) polymerase chain reaction (PCR) in plasma samples [55] .
Bacterial and protozoan STIs were tested in the 27 FSWs: antitreponemal antibodies were detected using the Treponema pallidum hemagglutination assay (TPHA; Fujirebio) and the rapid plasma reagin (RPR) test (Macro-Vue, Becton Dickinson). A diagnosis of syphilis was made if results for both the TPHA and RPR tests were positive [56] . Neisseria gonorrhoeae infection was diagnosed by culture on modified Thayer-Martin medium or by PCR [56] . Chlamydia trachomatis infection was diagnosed by Microtrak EIA (Syva) or by PCR. Trichomonas vaginalis infection was diagnosed by use of wet-mount techniques.
T cell activation markers. Phenotypic analyses of peripheral blood lymphocytes were performed on fresh whole blood within 4 h of collection in EDTA. To quantify the levels of CD4 ϩ and CD8 ϩ T cell activation, whole blood was incubated in the presence of the following monoclonal antibody (MAb) combinations: anti-CD8, anti-CD38, and anti-HLA-DR; anti-CD3, anti-CD8, and anti-HLA-DR; and anti-CD4, anti-CD45RO, and anti-CD62L MAbs. All MAbs were fluorochrome-labeled and purchased from Becton Dickinson. The whole-blood staining procedure was done as described elsewhere [57] . Samples were analyzed using a FACScan flow cytometer and CellQuest software (both from Becton Dickinson For all analyses, quadrant markers were set using negative isotype controls. HIV-1 coreceptor expression. Levels of HIV-1 coreceptor expression were analyzed on fresh whole blood within 4 h of collection in EDTA. Cells were stained with a combination of peridinin-chlorophyll-protein-labeled anti-CD4 and fluorescein isothiocyanate-labeled anti-CD45RO (both from Becton Dickinson), and phycoerythrin (PE)-labeled anti-CCR5 and anti-CXCR4 MAbs (both from Pharmingen), to assess the membrane expression of CCR5 and CXCR4 on CD45RO ϩ (memory) and CD45RO Ϫ (naive) CD4 ϩ lymphocytes. Whole- blood staining was done as described above for T cell activation markers. HIV-1 coreceptor expression levels were calculated as percentages of positive cells or as median logarithmic fluorescence intensity (MFI) levels. Intracellular staining of b-chemokines and cytokines. Peripheral blood mononuclear cells (PBMC) were separated from fresh whole blood within 4 h of collection and stained intracellularly for b-chemokines and cytokines, as described elsewhere [57] . In brief, PBMC were incubated overnight in the presence of monensin (1.5 mg/mL; Sigma) for the constitutive intracellular accumulation of the b-chemokine RANTES and for 5 h with PMA (0.02 mg/mL) and ionomycin (1 mg/mL) in the presence of brefeldin A (10 mg/mL) (all from Sigma) for the stimulation-induced intracellular accumulation of the b-chemokines macrophage inflammatory protein (MIP)-1a and MIP-1b and the cytokines interleukin (IL)-2, IL-4, interferon (IFN)-g, and tumor necrosis factor (TNF)-a. PBMC were subsequently surface stained for CD3 and CD8, fixed, permeabilized, and stained intracellularly with anti-RANTES or anti-MIP-1a (both from Pharmingen); anti-IL-2, anti-IL-4, anti-IFN-g, or anti-TNF-a (all from Becton Dickinson) PE-labeled MAbs; or anti-MIP-1b carboxyfluorescein-labeled MAb (R&D Systems) for 30 min at room temperature. Samples were analyzed using a FACScan flow cytometer and CellQuest software (both from Becton Dickinson). Percentages of b-chemokine-positive and cytokine-positive cells were analyzed within the CD4 ϩ and CD8 ϩ T cell subsets. For all analyses, quadrant markers were set using negative isotype controls. Statistical analysis. Because there were 2 different study periods and because we wanted to minimize bias as a result of changing laboratory conditions, ESN FSWs and blood donors with approximately the same date of laboratory analysis were used for comparisons ( for both groups). Median values n p 20 were calculated for normal and nonnormal distributions. Differences between groups were tested for statistical significance by use of the nonparametric Mann-Whitney U test. Correlation analyses were performed for all 27 subjects in both study groups by use of the nonparametric Spearman's rank correlation test. The level of significance for all statistical tests was set at P p . .05
RESULTS
Characteristics of the study population. The median age of the 27 ESN FSWs was 23 years (range, 17-37 years), compared with 23 years (range, 18-52 years) for the 27 female blood donors (
). The median duration of commercial sex P p .326 work reported by 27 ESN FSWs was 6 months (range, 1-120 months). Three FSWs (11%) reported doing commercial sex work for у3 years, 11 (41%) reported doing commercial sex work for 6 months to 3 years, and 13 (48%) reported doing commercial sex work for !6 months. The reported number of clients on the last working day ranged from 1 to 14 (median, 3 clients). Ten FSWs (37%) reported "always" using condoms, 14 (52%) reported "often" using condoms, and 3 (11%) reported "rarely" or "never" using condoms. The reported consistency in condom use decreased with prolonged duration of commercial sex work ( ; ) and increased r p Ϫ0.517 P p .006 with higher reported numbers of clients per day ( ; r p 0.554 ). The number of clients per day tended to decrease P p .003 with prolonged duration of commercial sex work (r p Ϫ ; 
Figure 2. CXCR4 median logarithmic fluorescence intensity (MFI) levels of CD45RO
Ϫ (naive) and CD45RO ϩ (memory) CD4 ϩ cell subsets for 20 female blood donors (white boxes), 10 human immunodeficiency virusexposed seronegative (ESN) female sex workers (FSWs) who had done sex work for !6 months (gray boxes), and 10 ESN FSWs who had done sex work for у6 months (black boxes). Box plots represent the lowest value, the 25th percentile, the 50th percentile (median), the 75th percentile, and the highest value, respectively, indicated by horizontal lines in ascending order. Differences between groups were tested for statistical significance by use of the nonparametric Mann-Whitney U test. P 1 , female blood donors vs. all ESN FSWs; P 2 , ESN FSWs who had done sex work for !6 months vs. ESN FSWs who had done sex work for у6 months.
ing laboratory conditions over time (figure 2). ESN FSWs who had done sex work for у6 months had lower CXCR4 MFI levels than did ESN FSWs who had done sex work for !6 months, reaching significant levels in the naive (CD45RO Ϫ ) CD4 ϩ T cell subset but not in the memory (CD45RO ϩ ) CD4 ϩ T cell subset. Although CXCR4 MFI levels on naive CD4 ϩ cells tended to correlate inversely with age among ESN FSWs ( ; ), this was not found to be the case r p Ϫ0.331 P p .106 among blood donors. In addition, duration of sex work did not correlate with age ( ; ) among ESN FSWs, r p 0.183 P p .360 and median age in the groups of ESN FSWs who had done sex work for у6 months or !6 months was not different (P p ). Therefore, age could be excluded as a significant con-.239 founding factor in the analysis. Among ESN FSWs, no associations were found between CXCR4 expression and the number of clients per day, consistency of condom use, or the occurrence of an STI.
ESN FSWs and blood donors had similar percentages of bchemokine-positive T cells. RANTES was the most abundant b-chemokine detected in both CD4
ϩ and CD8 ϩ T cells, being constitutively expressed at higher percentages than mitogen-stimulated MIP-1a or MIP-1b ( 
DISCUSSION
In Abidjan, Cô te d'Ivoire, HIV prevalence among FSWs has decreased extensively, from 89% in 1992 to 32% in 1998 [52] and 28% in 2000 (authors' unpublished data), thanks to intensive prevention efforts and increasing condom use. However, although reported condom use is high with clients (79% consistent condom use with clients during the last working day in 1998 [52, 60] ), only 20% of the FSWs use condoms consistently with their stable partners (authors' unpublished data). The HIV incidence among FSWs participating in a trial of microbicides during 1998-2000 was 4% [61] , which indicates that seronegative FSWs in Abidjan are still frequently exposed to HIV and are at risk of acquiring infection. In 2000, HIV seroprevalence among first-time blood donors (men and women) in Abidjan was estimated at 6% [62] . Ten percent of pregnant women attending an antenatal clinic in Abidjan during 1997-2000 were HIV seropositive [63] . These data indicate that, despite targeting a population that is at lower risk for HIV infection than HIV-seronegative FSWs, blood donors, especially young female blood donors, cannot be considered to be HIV unexposed.
In this study, a group of ESN FSWs was compared with a group of HIV-seronegative female blood donors for the presence of immunological factors that could contribute to decreased susceptibility to HIV infection. Our findings indicate that ESN FSWs and HIV-seronegative female blood donors have comparable expression levels of the HIV-1 coreceptor CCR5, b-chemokines, and Th1 or Th2 cytokines, but that ESN FSWs have significantly decreased levels of CXCR4 expression and significantly increased levels of CD8 ϩ T cell activation.
Increased CD8 ϩ T cell activation could be a sign of anti-HIV activity by HIV-specific CD8 ϩ cytotoxic T cells [48] . Indeed, several studies have described HIV-specific CTL responses in HIV-seronegative subjects in association with frequent sexual exposure to HIV [20, 21, 24, 25] . However, in the present study, , we did not observe any statistically significant association between T cell activation markers and the occurrence of protozoan or bacterial STIs. It is more likely that viral non-HIV concurrent infections and STIs (which we have not analyzed in this study), rather than protozoan or bacterial STIs, play a role in T cell activation among ESN FSW. Previous studies in Kenya and Ethiopia reported similar expression levels of CCR5 in ESN FSWs, compared with those in unexposed control subjects, as in our study, but found increased rather than decreased levels of CXCR4 [37, 38] . In these studies, however, HIV-1 coreceptor expression was measured on fresh or cryopreserved PBMC, whereas, in the present study, fresh whole blood was used. Variation in technical procedures can highly influence the analysis of HIV-1 coreceptor expression levels. This has been shown for prolonged sample storage before analysis, which causes increased CXCR4 and decreased CCR5 levels [65] and for density gradient isolated PBMC with significantly lower levels of CCR5 [66] and CXCR4 (authors' unpublished data), compared with whole blood. The use of different anticoagulants can also influence laboratory results [65, 66] .
Decreased levels of CXCR4 among ESN FSWs in our study were found to be associated with prolonged duration of sex work. This association was found to be independent from T cell activation, since T cell activation did not correlate with either CXCR4 expression or the duration of sex work. In vi-tro, HIV-1 envelope gp120 has been shown to down-regulate CXCR4 [67, 68] . Similarly, in vivo, chronic HIV infection results in down-regulation of CXCR4 expression [59, [69] [70] [71] . Therefore, in the same way as in HIV-infected subjects, chronic exposure to HIV among ESN FSWs could have caused the down-regulation of CXCR4. Alternatively, it is also possible that factors other than HIV are responsible for the down-regulation of CXCR4 in ESN FSWs, as has been reported for infection with human herpesvirus (HHV)-6 and HHV-7 [72, 73] or through allogeneic activation [74] , both of which could have been acquired gradually by FSWs who had done sex work for a prolonged duration.
The relevance of CXCR4 down-regulation in ESN FSWs as a correlate of protection against HIV infection remains unclear and can only be addressed in a longitudinal study. Theoretically, it is unlikely that CXCR4 plays a role, since primary HIV-1 strains that are sexually-transmitted, M-tropic strains predominantly use CCR5 as a coreceptor [27, 29, 75] , an observation that has been confirmed in Abidjan (authors' unpublished data). Moreover, the few reported cases of HIV-1 transmission via CXCR4 have all occurred in subjects homozygous for the 32-bp deletion in the CCR5 gene [76, 77] . As shown for other African populations [37, 78] , this 32-bp deletion has not been detected among ESN FSWs in Abidjan [79] . Still, it would be interesting to investigate whether the down-regulated CXCR4 expression among ESN FSWs could provide a protective mechanism against T-tropic HIV-1 viruses that selectively use CXCR4 as a coreceptor. If this were proven to be the case, as a mechanism, CXCR4 downregulation could have contributed to the selection of CCR5-using M-tropic HIV-1 strains in sexual transmission.
In most studies, b-chemokine levels in ESN subjects have been measured in plasma samples or in the supernatant of mitogen-stimulated lymphocyte cultures, without providing information on the identity of the cells that produced the bchemokines [36] [37] [38] [43] [44] [45] [46] . Therefore, we measured proportions of b-chemokine-producing CD4 ϩ and CD8 ϩ T cells in ESN FSWs by means of flow cytometry after spontaneous (for RANTES) and mitogen-stimulated (for MIP-1a and MIP-1b) intracellular accumulation in vitro. Our results show that proportions of b-chemokine-producing CD4 ϩ and CD8 ϩ T cells were comparable between ESN FSWs and blood donors and did not correlate with any indicative marker of HIV exposure of the FSWs. These data are in agreement with findings from other studies of ESN FSW populations [37, 38] . In a previous study, we found a positive correlation between proportions of b-chemokine-producing T cells and HIV-1 plasma virus load in HIV-1-infected FSWs, which indicates that intracellular bchemokine expression is a correlate of disease progression rather than of protection [57] . Proportions of T cells producing the Th1 cytokines IL-2, TNF-a and IFN-g were similar in ESN FSWs and blood donors. Nevertheless, production of Th1 cytokines correlated more clearly with in vivo T cell activation among the ESN FSWs than among blood donors. Therefore, our data are more in line with augmented T cell activation and Th1 cytokine production in ESN subjects, as reported elsewhere [48] and do not confirm a down-regulated Th1 cytokine profile in ESN subjects in association with a postulated HIV protective lowgrade activation state of CD4 ϩ T cells [51] . Our data also show comparable percentages of IL-4-producing T cells among ESN FSWs and female blood donors and, therefore, do not support the recent observation of a down-regulated Th2 cytokine profile in ESN FSWs [50] . In summary, we found that ESN FSWs in Abidjan have similar expression levels of the HIV-1 coreceptor CCR5, bchemokines, and Th1 and Th2 cytokines, compared with HIVseronegative female blood donors, but have significantly decreased levels of CXCR4 expression, together with significantly increased levels of T cell activation. These data indicate that ESN FSWs differ from female blood donors based on immunological factors that have no clear protective potential against HIV transmission.
